Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Toxins (Basel) ; 16(7)2024 Jul 17.
Artigo em Inglês | MEDLINE | ID: mdl-39057961

RESUMO

Citrinin (CIT), a polyketide mycotoxin produced by Penicillium, Aspergillus, and Monascus species, is a contaminant that has been found in various food commodities and was also detected in house dust. Several studies showed that CIT can impair the kidney, liver, heart, immune, and reproductive systems in animals by mechanisms so far not completely elucidated. In this study, we investigated the CIT mode of action on two human tumor cell lines, HepG2 (hepatocellular carcinoma) and A549 (lung adenocarcinoma). Cytotoxic concentrations were determined using an MTT proliferation assay. The genotoxic effect of sub-IC50 concentrations was investigated using the alkaline comet assay and the impact on the cell cycle using flow cytometry. Additionally, the CIT effect on the total amount and phosphorylation of two cell-cycle-checkpoint proteins, the serine/threonine kinase Chk2 and Fanconi anemia (FA) group D2 (FANCD2), was determined by the cell-based ELISA. The data were analyzed using GraphPad Prism statistical software. The CIT IC50 for HepG2 was 107.3 µM, and for A549, it was >250 µM. The results showed that sensitivity to CIT is cell-type dependent and that CIT in sub-IC50 and near IC50 induces significant DNA damage and cell-cycle arrest in the G2/M phase, which is related to the increase in total and phosphorylated Chk2 and FANCD2 checkpoint proteins in HepG2 and A549 cells.


Assuntos
Pontos de Checagem do Ciclo Celular , Quinase do Ponto de Checagem 2 , Citrinina , Dano ao DNA , Proteína do Grupo de Complementação D2 da Anemia de Fanconi , Neoplasias Hepáticas , Humanos , Quinase do Ponto de Checagem 2/metabolismo , Quinase do Ponto de Checagem 2/genética , Proteína do Grupo de Complementação D2 da Anemia de Fanconi/metabolismo , Proteína do Grupo de Complementação D2 da Anemia de Fanconi/genética , Células Hep G2 , Pontos de Checagem do Ciclo Celular/efeitos dos fármacos , Citrinina/toxicidade , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patologia , Células A549 , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patologia , Adenocarcinoma/patologia , Adenocarcinoma/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA